Previous 10 | Next 10 |
Gainers: Willamette Valley Vineyards (WVVI) +55%.Ocular Therapeutix (OCUL) +23%.Galera Therapeutics (GRTX) +23%.JAKKS Pacific (JAKK) +21%.ShiftPixy (PIXY) +19%.1-800-FLOWERS.COM (FLWS) +18%.MEDIROM Healthcare Technologies (MRM) +16%.VEREIT (VER) +16%.Communications Systems (JCS) +15%.Dol...
Gainers: Galera Therapeutics (GRTX) +26%, Ocular Therapeutix (OCUL) +17%, Capricor Therapeutics (CAPR) +15%, AtriCure (ATRC) +12%, Atossa Therapeutics (ATOS) +14%.Losers: Adverum Biotechnologies (ADVM) -60%, Cara Therapeutics (CARA) -44%,...
Brooklyn ImmunoTherapeutics (BTX) announced the acquisition of an exclusive license for mRNA gene editing and cell therapies technology from Factor Bioscience Limited and Novellus Therapeutics Limited.The acquisition follows an exercise of a previously announced option. ‘The ...
Should Investors Buy These Health Care Stocks Before May 2021? We are still seeing COVID-19 cases rising around the globe despite having vaccines rolled out globally. This has undoubtedly allowed health care stocks to remain in the limelight. So it’s likely that investors...
Shares of Brooklyn ImmunoTherapeutics (BTX) have hit another 52-week high today and are up 66%, despite no catalysts, SEC filings, or news that might explain the run-up.At its highest today, shares traded at $44.48, ~79% above yesterday's closing price.Less than a week ago, the company record...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...
Gainers: ADMA Biologics (ADMA) +25%, Brooklyn ImmunoTherapeutics (BTX) +23%, Clover Health Investments (CLOV) +15%, Neptune Wellness Solutions (NEPT) +12%, Akouos (AKUS) +11%.Losers: Protalix BioTherapeutics (PLX) -40%, Benitec Bioph...
Protalix BioTherapeutics (PLX) -43% on FDA rejection of experimental therapy for Fabry disease.Benitec Biopharma (BNTC) -22% after secures $13M capital via equity offering.Urban Tea (MYT) -13% on 1H earnings releasePinterest (PINS) -12% on Q1 earnings releas...
Gainers: Tian Ruixiang (TIRX) +54%.Vaxart (VXRT) +51%.RiceBran Technologies (RIBT) +47%.Aldeyra Therapeutics (ALDX) +31%.NetSol Technologies (NTWK) +30%.First Choice Bancorp (FCBP) +28%.TrueBlue (TBI) +26%.Brooklyn ImmunoTherapeutics (BTX) +23%.Big Rock Partners Acquisition (BRPA) +23%.T...
Gainers: Reviva Pharmaceuticals RVPH +41%, Ocugen OCGN +22%, Axsome Therapeutics AXSM +12%, AcelRx Pharmaceuticals (ACRX) +9%, Voyager Therapeutics VYGR +8%.Losers: MiMedx (MDXG) -9%, Shineco (TYHT) -8%, Brooklyn ImmunoTherapeut...
News, Short Squeeze, Breakout and More Instantly...
Brooklyn ImmunoTherapeutics Inc. Company Name:
BTX Stock Symbol:
NYSE Market:
Brooklyn ImmunoTherapeutics Inc. Website:
New name reflects Company focus on leveraging exclusively in-licensed foundational mRNA cell engineering patent portfolio The Eterna corporate mission is to realize the potential of cell engineering to provide patients with transformational new medicines Company’s...
SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”) today announces results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnos...
SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, today ann...